Blood pressure risk factors in early adolescents: results from a Ugandan birth cohort by Lule, SA, Akurut, H, Nampijja, M, Akello, F, Tumusiime, J, Aujo, JC, Oduru, G, Mentzer, AJ, Smeeth, L, Elliott, AM, Webb, EL

Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A by Wajja, A, Namutebi, M, Apule, B, Oduru, G, Kiwanuka, S, Akello, M, Nassanga, B, Kabagenyi, J, Mpiima, J, Vermaak, S, Lawrie, A, Satti, I, Verweij, J, Cose, S, Levin, J, Kaleebu, P, Tukahebwa, E, McShane, H, Elliott, A

Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control by Wajja, A, Nassanga, B, Natukunda, A, Serubanja, J, Tumusiime, J, Akurut, H, Oduru, G, Nassuuna, J, Kabagenyi, J, Morrison, H, Scott, H, Powell Doherty, R, Marshall, JL, Cabrera Puig, I, Cose, S, Kaleebu, P, Webb, EL, Satti, I, McShane, H, Elliott, AM

Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-labe... by Wajja, A, Nassanga, B, Natukunda, A, Serubanja, J, Tumusiime, J, Akurut, H, Oduru, G, Nassuuna, J, Kabagenyi, J, Morrison, H, Scott, H, Doherty, RP, Marshall, JL, Puig, IC, Cose, S, Kaleebu, P, Webb, EL, Satti, I, McShane, H, Elliott, AM, TB042 Study Team